CNHC logo

China Health Management Corp. (CNHC)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CNHC steht fuer China Health Management Corp., ein Financial Services-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Die Aktie erzielt 53/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 16. März 2026
53/100 KI-Bewertung

China Health Management Corp. (CNHC) Finanzdienstleistungsprofil

CEOXu Mei
Mitarbeiter56
HauptsitzDallas, US
IPO-Jahr1997

China Health Management Corp., based in Dallas, focuses on managing and operating hospitals in China, providing diverse healthcare services such as gynaecology, paediatrics, and surgery. With a P/E ratio of 14.15 and a profit margin of 33.2%, the company navigates the financial services sector as a shell company.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

China Health Management Corp. presents a unique investment profile as a shell company operating in the Chinese healthcare sector. With a P/E ratio of 14.15 and a profit margin of 33.2%, the company demonstrates profitability. Key value drivers include its focus on hospital management and diverse service offerings. Growth catalysts may arise from expanding healthcare services and penetrating new markets within China. However, potential risks include regulatory challenges, competition, and the complexities of operating in the Chinese healthcare system. The company's beta of -1.56 suggests low volatility relative to the market. Investors should carefully evaluate these factors to assess the investment opportunity.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Profit Margin of 33.2% indicates strong profitability in its healthcare operations.
  • Gross Margin of 47.3% reflects efficient cost management in service delivery.
  • P/E Ratio of 14.15 suggests a potentially undervalued stock compared to industry peers.
  • Beta of -1.56 indicates low volatility relative to the market, potentially offering stability.
  • The company manages 56 employees, reflecting a relatively lean operational structure.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diverse range of healthcare services.
  • Experienced management team.
  • Established presence in China.
  • High profit margin of 33.2%

Schwaechen

  • Small market capitalization.
  • Limited geographic reach.
  • Dependence on the Chinese healthcare market.
  • OTC listed - potential liquidity concerns

Katalysatoren

  • Upcoming: Expansion of healthcare services to meet growing demand in China (Timeline: Ongoing).
  • Upcoming: Penetration of new geographic markets within China (Timeline: 2027-2030).
  • Ongoing: Strategic partnerships with established healthcare providers and technology companies.
  • Ongoing: Investment in digital health initiatives to improve access to healthcare services (Timeline: 2026-2028).
  • Ongoing: Focus on preventive medicine and wellness programs to attract a broader customer base.

Risiken

  • Potential: Regulatory changes in the Chinese healthcare system could impact operations.
  • Potential: Competition from larger, more established healthcare providers.
  • Potential: Economic downturn in China could reduce demand for healthcare services.
  • Potential: Geopolitical risks affecting international operations.
  • Ongoing: Limited financial disclosure and transparency due to OTC listing.

Wachstumschancen

  • Expanding Healthcare Services: China Health Management Corp. can grow by expanding its range of healthcare services to meet the increasing demand for specialized medical treatments. This includes investing in advanced medical technologies and attracting skilled healthcare professionals. The market for specialized healthcare services in China is projected to reach $500 billion by 2030, offering significant growth potential. Timeline: Ongoing.
  • Penetrating New Markets: The company can penetrate new geographic markets within China to increase its market share. This involves establishing new hospital partnerships and expanding its service network. The Chinese healthcare market is vast and diverse, with significant opportunities in underserved regions. Market size: $1 trillion by 2028. Timeline: 2027-2030.
  • Strategic Partnerships: Forming strategic partnerships with established healthcare providers and technology companies can enhance the company's capabilities and expand its reach. This includes collaborating on research and development, sharing best practices, and integrating innovative technologies. The partnership market in healthcare is expected to grow by 15% annually. Timeline: Ongoing.
  • Digital Health Initiatives: Investing in digital health initiatives, such as telemedicine and online consultations, can improve access to healthcare services and enhance patient engagement. This includes developing mobile apps and online platforms for remote monitoring and virtual care. The digital health market in China is projected to reach $200 billion by 2027. Timeline: 2026-2028.
  • Focus on Preventive Medicine: Expanding its focus on preventive medicine and wellness programs can attract a broader customer base and generate recurring revenue streams. This includes offering health screenings, lifestyle coaching, and disease management programs. The preventive medicine market in China is growing rapidly, driven by increasing awareness of health and wellness. Market size: $100 billion by 2026. Timeline: Ongoing.

Chancen

  • Expanding healthcare services to meet growing demand.
  • Penetrating new geographic markets within China.
  • Forming strategic partnerships with established healthcare providers.
  • Leveraging digital health technologies to improve access and efficiency.

Risiken

  • Regulatory changes in the Chinese healthcare system.
  • Competition from larger, more established healthcare providers.
  • Economic downturn in China.
  • Geopolitical risks affecting international operations.

Wettbewerbsvorteile

  • Established presence in the Chinese healthcare market.
  • Diverse range of healthcare services offered.
  • Expertise in hospital operations and management.

Ueber CNHC

China Health Management Corp., originally incorporated as Max Internet Communications, Inc. in 1996, transitioned to its current focus in March 2006. Headquartered in Dallas, Texas, the company operates as a healthcare and management entity with a specific emphasis on the Chinese market. Its core business revolves around the operation and management of hospitals, offering a wide array of medical services. These services span various medical disciplines, including gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology, otolaryngology, anesthesia, and haemodialysis. Beyond these specialized areas, China Health Management Corp. provides essential medical services such as surgery, emergency medicine, intensive care, preventive medicine, and pharmacy. The company also offers psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, and medical functions examination. Furthermore, it engages in commissioning hospital management and provides hospital management consultation services. The company's comprehensive approach aims to deliver integrated healthcare solutions within the Chinese healthcare landscape.

Was das Unternehmen tut

  • Operates and manages hospitals in China.
  • Provides gynaecology and obstetrics services.
  • Offers paediatrics services.
  • Provides stomatology and dermatology services.
  • Offers medical cosmetology services.
  • Provides pathology, ophthalmology, and otolaryngology services.
  • Offers anesthesia and haemodialysis services.
  • Provides surgery, emergency medicine, and intensive care.

Geschaeftsmodell

  • Generates revenue through hospital operations and management fees.
  • Earns income from providing a wide range of healthcare services.
  • Derives revenue from medical consultations and examinations.

Branchenkontext

China Health Management Corp. operates within the financial services sector as a shell company focused on healthcare management in China. The healthcare industry in China is experiencing growth, driven by increasing demand for medical services and government initiatives to improve healthcare access. The competitive landscape includes both domestic and international healthcare providers. China Health Management Corp. differentiates itself through its specialized hospital management services and diverse medical offerings. However, the company faces competition from larger, more established players in the market. The industry is also subject to regulatory changes and evolving healthcare policies.

Wichtige Kunden

  • Patients seeking gynaecology and obstetrics services.
  • Parents seeking paediatrics services for their children.
  • Individuals seeking stomatology and dermatology services.
  • Patients requiring surgery, emergency medicine, and intensive care.
KI-Zuversicht: 69% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

China Health Management Corp. (CNHC) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CNHC verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CNHC.

Kursziele

Wall-Street-Kurszielanalyse fuer CNHC.

MoonshotScore

53/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CNHC auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Klassifizierung

Branche Shell Companies

Fuehrung: Xu Mei

CEO

Xu Mei serves as the CEO of China Health Management Corp., leading a team of 56 employees. Information regarding Xu Mei's detailed career history, educational background, and previous roles is not available. Further research is needed to provide a comprehensive profile of Xu Mei's professional background and credentials.

Erfolgsbilanz: Due to limited information available, a detailed track record of Xu Mei's key achievements, strategic decisions, and company milestones under their leadership cannot be provided. Further research is needed to assess their impact on China Health Management Corp.'s performance and growth.

CNHC OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that China Health Management Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and requires careful due diligence from investors.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for stocks trading on the OTC Other tier is typically very low, with wide bid-ask spreads and limited trading volume. This can make it difficult to buy or sell shares without significantly impacting the price. Investors should be prepared for potential delays in executing trades and the possibility of incurring higher transaction costs due to the illiquidity of the stock.
OTC-Risikofaktoren:
  • Limited Financial Disclosure: Lack of transparency in financial reporting increases investment risk.
  • Low Liquidity: Difficulty in buying or selling shares can lead to significant price fluctuations.
  • Regulatory Scrutiny: OTC Other stocks are subject to less regulatory oversight, increasing the potential for fraud or mismanagement.
  • Volatility: Higher price volatility due to low trading volume and speculative trading.
  • Going Concern Risk: Companies in this tier may face financial difficulties and have a higher risk of bankruptcy.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Check for any red flags or warning signs, such as frequent changes in auditors or management.
  • Understand the risks associated with investing in OTC Other stocks.
  • Consult with a financial advisor before making any investment decisions.
Legitimitaetssignale:
  • Operational History: The company has been operating since 1996, indicating some level of business continuity.
  • Healthcare Focus: The company's focus on healthcare services aligns with a growing market demand in China.
  • Employee Base: The company employs 56 people, suggesting a functional operational structure.

Haeufige Fragen zu CNHC

What are the key factors to evaluate for CNHC?

China Health Management Corp. (CNHC) currently holds an AI score of 53/100, indicating moderate score. Key strength: Diverse range of healthcare services.. Primary risk to monitor: Potential: Regulatory changes in the Chinese healthcare system could impact operations.. This is not financial advice.

How frequently does CNHC data refresh on this page?

CNHC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CNHC's recent stock price performance?

Recent price movement in China Health Management Corp. (CNHC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse range of healthcare services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CNHC overvalued or undervalued right now?

Determining whether China Health Management Corp. (CNHC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CNHC?

Before investing in China Health Management Corp. (CNHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CNHC to a portfolio?

Potential reasons to consider China Health Management Corp. (CNHC) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse range of healthcare services.. Additionally: Experienced management team.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CNHC?

Yes, most major brokerages offer fractional shares of China Health Management Corp. (CNHC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CNHC's earnings and financial reports?

China Health Management Corp. (CNHC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CNHC earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on CEO track record.
  • OTC Other stocks carry higher risk than exchange-listed stocks.
  • AI analysis pending for CNHC.
Datenquellen

Popular Stocks